(19)

(11)

EP 4 469 147 A1

(12)

(43) Date of publication: 04.12.2024 Bulletin 2024/49 (21) Application number: 22922501.6 (22) Date of filing: 14.11.2022

(51) International Patent Classification (IPC):  A61N 5/06(2006.01) A61B 90/98(2016.01) A61N 5/067(2006.01) A61M 39/10(2006.01) (52) Cooperative Patent Classification (CPC): A61B 90/98; A61N 5/067; A61M 2205/8206; A61M 2205/18; A61M 2205/6063; A61M 2205/583; A61M 2205/581; A61M 2205/051; A61M 2039/167; A61M 39/16; A61M 2039/1077; A61N 2005/063; A61N 2005/0612; A61N 5/0601; A61B 18/24; A61B 2018/2288 (86) International application number: PCT/US2022/079811 (87) International publication number: WO 2023/140973 (27.07.2023 Gazette 2023/30)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 20.01.2022 US 202217579657 (71) Applicant: Light Line Medical, Inc. Salt Lake City, UT 84108 (US)	(72) Inventors: LONG, Curtis Salt Lake City, Utah 84104 (US) CROLL, Perry Sandy, Utah 84092 (US) (74) Representative: Murgitroyd & Company  165-169 Scotland Street Glasgow G5 8PL Glasgow G5 8PL (GB)